New biologic therapeutics for ulcerative colitis and Crohn's disease
S Mozaffari, S Nikfar, AH Abdolghaffari… - Expert opinion on …, 2014 - Taylor & Francis
Introduction: Some inflammatory bowel disease (IBD) patients especially those with
refractory Crohn's disease (CD) or relapsing ulcerative colitis (UC) do not respond to current …
refractory Crohn's disease (CD) or relapsing ulcerative colitis (UC) do not respond to current …
New biologic therapeutics for ulcerative colitis and Crohn's disease.
S Mozaffari, S Nikfar, AH Abdolghaffari… - Expert Opinion on …, 2014 - europepmc.org
Some inflammatory bowel disease (IBD) patients especially those with refractory Crohn's
disease (CD) or relapsing ulcerative colitis (UC) do not respond to current therapies. The …
disease (CD) or relapsing ulcerative colitis (UC) do not respond to current therapies. The …
[引用][C] New biologic therapeutics for ulcerative colitis and Crohn's disease
S Mozaffari, S Nikfar, AH Abdolghaffari… - Expert Opinion on …, 2014 - cir.nii.ac.jp
New biologic therapeutics for ulcerative colitis and Crohn's disease | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
New biologic therapeutics for ulcerative colitis and Crohn's disease
S Mozaffari, S Nikfar… - Expert opinion on …, 2014 - pubmed.ncbi.nlm.nih.gov
Introduction Some inflammatory bowel disease (IBD) patients especially those with
refractory Crohn's disease (CD) or relapsing ulcerative colitis (UC) do not respond to current …
refractory Crohn's disease (CD) or relapsing ulcerative colitis (UC) do not respond to current …